Form 4: C3.ai Director Granted Stock Options

C3.ai director Michael Wayne Clayville was granted 34,091 stock options with a $15.92 exercise price, vesting over two years.

Summary

• Director Michael Wayne Clayville of C3.ai, Inc. was granted 34,091 stock options.
• The options have an exercise price of $15.92 per share.
• The grant date for these options is December 11, 2025.
• The options will vest at a rate of 12.5% on the last day of each fiscal quarter over a two-year period, starting from December 11, 2025.
• Vesting is contingent upon Mr. Clayville remaining a director of the Company and attending in-person regularly scheduled Board meetings each fiscal quarter.
• Unvested shares due to missed attendance can vest after the two-year anniversary if subsequent attendance requirements are met.
• The options expire on December 10, 2035.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. It's a routine compensation event, but the grant of options aligns director interests with long-term shareholder value, which is generally positive. No immediate financial impact or performance data is provided.

Positives

• The grant of stock options to a director aligns the director's interests with long-term shareholder value.
• The vesting schedule incentivizes continued service and active participation on the Board.

Negatives

• No immediate cash transaction or direct share purchase, so no immediate positive signal of the director's personal capital commitment.

Risks

• Vesting is conditional on continued directorship and meeting attendance, meaning the options could be forfeited if conditions are not met.
• The value of the options is dependent on C3.ai's stock price exceeding the $15.92 exercise price.

Future Outlook

The grant of long-term stock options suggests an expectation of future growth and value creation for C3.ai, incentivizing the director to contribute to this growth over the vesting period.

Industry Context

Stock option grants are a common form of executive and director compensation in the technology sector, particularly for growth-oriented companies like C3.ai, which operates in the AI software space. This practice aims to align leadership incentives with long-term company performance and shareholder returns.

Comparison to Industry Standards

• Granting stock options to directors is a standard practice in the technology industry, similar to companies like Palantir Technologies (PLTR) or Snowflake (SNOW), which often use equity compensation to attract and retain talent and align interests.
• The vesting schedule, tied to continued service and board attendance, is a common mechanism to ensure active engagement and long-term commitment from directors.
• The exercise price being set at the market price on the grant date (implied by $0 price of derivative security and the nature of a stock option) is also standard for incentive options.

Related Party Transactions

• The grant of stock options to Director Michael Wayne Clayville is a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: Potential dilution if options are exercised, but also potential for increased director alignment with long-term share price appreciation.

Next Steps

• Continued service by Michael Wayne Clayville as a director of C3.ai.
• Regular attendance by Mr. Clayville at Board meetings to ensure vesting of options.
• Potential exercise of options by Mr. Clayville after vesting and if the stock price is favorable.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a director, which is a standard compensation practice. It does not provide new information about the company's financial performance, strategic direction, or market position that would warrant a change in investment recommendation. The grant aligns the director's interests with long-term shareholder value, which is a neutral to slightly positive factor, but not enough to alter a fundamental investment thesis. Therefore, a "hold" recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

C3.ai, AI, Stock Option, Director Compensation, Insider Transaction, Form 4, Equity Grant, Vesting